We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

0001437749-19-009842 Sample Contracts

AMENDMENT TO STOCK PURCHASE AND SALE AGREEMENT
Stock Purchase and Sale Agreement • May 14th, 2019 • Progenics Pharmaceuticals Inc • Pharmaceutical preparations

This Amendment to Stock Purchase and Sale Agreement (this “Amendment”) is made as of the 9th day of May, 2019, by and among Highland Capital Management, L.P., solely in its capacity as stockholders’ representative (the “Stockholders Representative”), Molecular Insight Pharmaceuticals, Inc. (“MIP”), and Progenics Pharmaceuticals, Inc. (“Progenics”).